Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-722-4 | CAS number: 120570-77-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 2,2'-oxybis-ethanol diformate
- EC Number:
- 601-722-4
- Cas Number:
- 120570-77-6
- Molecular formula:
- C6H10O5
- IUPAC Name:
- 2,2'-oxybis-ethanol diformate
- Details on test material:
- - Name of test material (as cited in study report): 2,2-Oxybis-ethanol diformate (Diethylene Glycol Diformate)
- Analytical purity: no data
For OECD 471, OECD 473, OECD 490, OECD 414 and OECD 408
Name of test material (as cited in the tstudy report): Diethylene glycol diformate
CAS No. 120570-77-6
Chemical Name (IUPAC) : 2,2’-oxybis-ethanol diformate:
Physical Appearance : Clear pale-yellow liquid, free from suspended matter
Purity (as per CoA) : 96.1%
Batch No. : 26088
Manufactured Date : 07 July 2019
Retest Date : 06 July 2021
Recommended Storage Condition: Ambient(+18 to +36ºC)
pH: 2.8 at 30% water solution
density: 1.19 at 20°C
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hylasco Biotechnology (India) Pvt. Ltd. Plot 4B, MN Park, Shameerpet Mandal, Turkapally Village, Medchal District, Telangana -500078
-Age at the study initiation: 12 and 13 weeks
- Weight at study initiation: Mean body weight of Day 0 mated females
G1 : 241.99 ± 14.44
G2: 241.64 ± 11.95
G3: 242.38 ± 16.18
G4: 244.98 ± 15.63
The weight variation of rats was minimal and did not exceed ± 20 % of the mean body weight in each group.
- Housing: standard polysulfone rat cages (size: Length 425 mm x Breadth 266 mm x Height 185 mm) with stainless steel top grill having facilities for pellet food and drinking water in polycarbonate bottle with stainless steel sipper tube. Additionally, polycarbonate rat huts were placed inside the cage as environmental enrichment objects which were replaced once a week.
i.Pre mating / Acclimatization: Two rats of the same sex per cage were housed.
ii. Mating: Female rats were cohabited with males in a 1:1 ratio in same cage.
iii. Post-mating / Treatment: After mating confirmation, females were housed individually. Nesting material (paper cuttings) were placed inside the cages from GD 18 onwards.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: After detailed clinical examination for good health and suitability for the study, 120 females and 50 male rats were acclimatized for five days before initiation of mating. Only nulliparous and non-pregnant females were used in the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22°C
- Humidity (%): 64-66%
- Air changes (per hr): 12 to 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12hrs dark/12 hrs light
IN-LIFE DATES: From: acclimatisation, mating period to 20 GD (females)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dose formulations were prepared fresh daily before dosing and used within the established stability period of 5 hours.
Based on the dose, required quantities of the test item was weighed in a beaker for each dose levels separately and small volume of vehicle [Milli-Q water] was added and stirred using a glass rod till a uniform solution was obtained. This was then transferred in to a measuring cylinder and the volume was made up to the required level using the vehicle to get the final desired concentrations of 10 (G2), 30 (G3) and 100 (G4) mg/mL.
VEHICLE
- Concentration in vehicle: from 0 to 100 mg/ml
- Amount of vehicle (if gavage): 10 ml (doe volume)
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples for analysis of active ingredient (a.i.) were collected from the dose formulations intended for first treatment and last treatment (-4 days) for the first
batch of rats. The prepared formulations were sampled in duplicate sets wherein one set was used for analysis and another as back up set which was
stored at ambient condition. For each set, composite samples were drawn from each dose formulation including vehicle control. The samples collected (both
the sets) were sent to Analytical R&D of Eurofins Advinus Ltd. for formulation analysis to determine the concentration of the dose formulation.
Dose formulation samples were analyzed for Diethylene Glycol Diformate content using analytical method which was validated
Dose formulations samples are considered acceptable if results are within ± 10.0 % of the claimed concentration and the relative standard deviation (% RSD), of assay is less than or equal to 5 %.
As the results from low dose from the first preparation was above the acceptance criteria, samples from subsequent preparation was used for analysis. - Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1:1
- Length of cohabitation: until vaginal smear/vaginal plug exhibited sperm
the cohabitation continued until tehre was enough umber of pregnant females for the study
- Further matings after two unsuccessful attempts: [no / yes (explain)]: no
- Verification of same strain and source of both sexes: [yes / no (explain)]: no
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy: both vaginal plug and vaginal smear refered as Day 0 - Duration of treatment / exposure:
- gestation day 5 to gestation day 19
- Frequency of treatment:
- once daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 24 for each dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: based on a a preliminary dose range finding study (DRF) in pregnant rats carried out using 7 rats per group with Diethylene Glycol Diformate dosed at 100, 300 and 1000 mg/kg/day along with the concurrent vehicle control group. The rats were treated with the dose formulations by oral gavage at a dose volume of 10 mL/kg body weight from GD 5 to 19 and observed for clinical signs, mortality and bodyweight change and food consumption. The uteri were weighed and examined for the number of implantation sites, early and late resorptions, and number of live or dead fetuses. The number of corpora lutea was counted. All the fetuses were weighed, sexed, measured for anogenital distance, and examined for external malformations.
In this study, dose levels up to 1000 mg/kg/day were tolerated. No test item related clinical signs were noted at any dose. The body weight gains and food consumption were unaffected up to the highest dose of 1000 mg/kg/day. There was no fetal developmental toxicity up to the highest tested dose of 1000 mg/kg/day.
- stability of the dose solutions : The stability of Diethylene glycol diformate in vehicle was established at concentration of 0.1 and 150 mg/mL under validated method. The results indicated that the test item was stable and homogenous in the vehicle for 5 hours at both the concentrations when stored at room temperature.
Examinations
- Maternal examinations:
-
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: During acclimatization period, all the rats were observed once daily.
Observations for clinical signs were performed twice a day, pre dose and post dose (30 minutes to 2 hour post dose, approx.) during treatment days and at least once on other days.
Each rat was observed twice daily during treatment period for morbidity and mortality i.e., once in the morning and once in the afternoon. Based on the assessment as there were no clinical signs of concern, the observation for morbidity and mortality was carried out once during weekends and public holidays
BODY WEIGHT: Yes
- Time schedule for examinations: All females included in the study were weighed on gestation days 0, 3, 5, 8, 11,
14, 17 and 20.
FOOD CONSUMPTION : Yes, About 200 g of food (food input) was provided on Day 0. The food output was recorded and replenished to about 200 g on Days 3, 5, 8, 11, 14 and 17 and food output on Day 20 of presumed gestation was recorded.
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes / No / No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 20
- Organs examined: gross pathological changes in placenta and in all visceral organs. Gross necropsy involved external observation and examination of thoracic and abdominal viscera including uterine contents. At necropsy, thyroid gland was collected and weighed from each rat (post fixation) and subjected to histopathological examination. The tissue was processed for routine paraffin embedding and 4-5 micron sections were stained with Mayer’s Haematoxylin and Eosin stain. Unused tissue will be archived.
List of analysed organs: eyes, bone, joints, femorotibial, gut associated lymphoid tissue, heart, ileum jejunum, kidneys, liver, lungs, mammary glands, lymph nodes, optic nerve, ovaries, oviducts, pancreas, pituitary gland, rectum, skin, sciatic nerve, salivary glands, spinal cord, spleen, sternum, stomach, thymus, thyroid and parathyroid, trachea, urinary bladder, uterus vagina.
- Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantation sites: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: gross evaluation of placenta
The ovaries and uterine content was examined after termination: Yes / No / No data
Examinations included:
- Gravid uterus weight: Yes / No / No data
- Number of corpora lutea: Yes / No / No data
- Number of implantations: Yes / No / No data
- Number of early resorptions: Yes / No / No data
- Number of late resorptions: Yes / No / No data
- Other: gross placenta analysis
Uteri that appeared non-gravid were subjected to 10% ammonium sulphide staining to observe implantation sites if any (identified as pregnant rats) or to confirm the non-pregnant status. - Fetal examinations:
- - External examinations: Yes:, all fetuses
- Soft tissue examinations: Yes, half per litter
- Skeletal examinations: Yes, half per litter
- Head examinations: Yes, half per litter
Moreover the following information were recorded:
Total number of fetuses
b. Number of live fetuses
c. Individual fetal body weight (g)
d. Anogenital distance (mm) from all live fetuses
e. Fetus sex -external determination based on anogenital distance that was confirmed based on gonadal examination (internal sex) during visceral examination. - Statistics:
- The data on maternal body weight, body weight change in interval, gravid uterine weight, body weight change corrected to gravid uterine weight, maternal food consumption, hormone analyses (T4, T3, TSH), weight of thyroid gland was analyzed using Analysis of Variance (ANOVA) after testing for homogeneity for intra group variance using Levene’s test. Where intra group variances were heterogeneous, ANOVA was performed after suitable transformation of data. Dunnett’s pairwise comparison of the treated group means with the control group mean was performed, when the group differences were found significant.
Fetal weight for male and female was analyzed using Analysis of Covariance (ANCOVA) taking litter size as covariate for group. Anogenital distance for
male and female was analyzed using Analysis of Covariance (ANCOVA) taking weight as covariate for group.
Number of corpora lutea, number of implantations, early and late resorptions, pre-implantation and post-implantation loss observations were analyzed using
Kruskal Wallis test for group comparison. Wilcoxon pairwise comparison of the treated groups with the control group was performed, when the group
differences were significant. - Indices:
- The incidence of dams with resorptions were tested for using Chi-square test followed by Fisher’s exact test for group association.
The incidence of fetus and litter (incidence and percent) observations for external, visceral and skeletal observations were tested using Cochran Armitage trend test and pair wise comparison will be tested by Fisher’s exact test for group association.
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- There was no morbidity or mortality and the treated rats were normal throughout the experimental period at all the doses tested.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- The maternal absolute mean body weights were unaffected by treatment up to the highest dose of 1000 mg/kg/day. The absolute mean body weight gains were also comparable between vehicle control and treatment groups except for
occassional significant decrease during gestation days 8-11 (19% lower v/s vehicle control) and 17-20 (9% lower v/s vehicle control) were considered incidental due to the pattern of occurance, lack of dose dependency. Further the corrected body weight gain was also unaffected by treatment up to the highest dose of 1000 mg/kg/day, hence the decreases seen in body weight gains were considered incidental. - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- The maternal mean food consumption was unaffected by treatment up to the highest dose of 1000 mg/kg/day.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- There were no gross pathological findings in any of the test item treated rats or vehicle control rats at necropsy.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- Thyroid hormone levels (T3, T4 and TSH) were not affected across the treated groups when compared to the vehicle control group. There were no treatment-related changes in thyroid gland weights or microscopic alterations in all groups compared to the vehicle control group.
Maternal developmental toxicity
- Number of abortions:
- no effects observed
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- not specified
- Early or late resorptions:
- no effects observed
- Dead fetuses:
- no effects observed
- Changes in pregnancy duration:
- not specified
- Changes in number of pregnant:
- not specified
- Details on maternal toxic effects:
- No test item related changes were observed in maternal parameters (mean uterine weights, mean number of corpora lutea, implantations, early and late resorptions, pre-and post-implantation loss rates and rats with any resorption) at any dose tested. Gross evaluation of placenta revealed no findings
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- body weight and weight gain
- clinical signs
- early or late resorptions
- food consumption and compound intake
- gross pathology
- mortality
- number of abortions
- pre and post implantation loss
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- The litter parameters (mean fetal weight and number of live fetuses) were comparable between the Vehicle control group and rats treated up to the highest dose of 1000 mg/kg/day
- Reduction in number of live offspring:
- no effects observed
- Description (incidence and severity):
- no dead fetusea were recorded
- Changes in sex ratio:
- no effects observed
- Description (incidence and severity):
- The anogenital distance in male and female fetuses were comparable to the concurrent Vehicle control
- External malformations:
- no effects observed
- Description (incidence and severity):
- No test item-related changes were observed during external observations of fetuses of rats treated up to 1000 mg/kg/day.
- Skeletal malformations:
- no effects observed
- Description (incidence and severity):
- There were no skeletal malformations observed in any litter at any of the tested dose levels except for one fetus from a dam (Rs9216) at 100 mg/kg/day which had absent caudal vertebrae, and 3rd and 4th sacral vertebrae which was
expected in a fetus which had thread like tail during external examination. Further similar observations were not observed at higher doses and hence the observed malformation was attributed to random occurence and not related to
treatment.
Few incidences of anomalies showed significant increase such as bilateral accessory rib No.14 at 300 mg/kg/day and right rudimentary rib No.14 at 1000 mg/kg/day as compared to vehicle control group. These incidences were
randomly distributed across the treatment and control groups and were not dose-related, consistent with historical controls and hence considered not related to treatment. - Visceral malformations:
- no effects observed
- Description (incidence and severity):
- No test item-related changes were observed during fresh visceral examination of fetuses of rats treated up to 1000 mg/kg/day. However, incidences of variations / anomalies such as incidence of fetus with slight renal pelvis dilation at 1000 mg/kg/day (1/162 fetuses) and incidence of fetus with moderate renal pelvis dilation at 1000 (1/162 fetuses). These incidences were statistically comparable to vehicle control group. The incidence is attributed to random occurence that is consistent with historical controls.
Fetal heads in all dose groups were normal when subjected to Wilsons Razor blade sectioning
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- reduction in number of live offspring
- fetal/pup body weight changes
- external malformations
- skeletal malformations
- visceral malformations
Overall developmental toxicity
- Developmental effects observed:
- no
Any other information on results incl. tables
refer to the attached final report for detailed tables and further information
Applicant's summary and conclusion
- Conclusions:
- The substance was tested pre-natal developmental toxicity to rats by oral route following OECD 414. Under the experimental conditions the NOAEL for maternal toicity was equal to 1000 mg/kg bw /day and for developmetal toxicity to 1000 mg/kg bw /day.
- Executive summary:
The substance was tested for pre-natal developmental toxicity in rats buy oral route following OECD 4141. The objective of this study was to evaluate the developmental toxicity
(teratogenic) potential of the test item Diethylene Glycol Diformate to cause adverse effects on the pregnant female rats and development of the embryo and fetus consequent to exposure of Diethylene Glycol Diformate to pregnant rats by oral route during gestation days (GD) 5 to 19.
A total 96 of Day 0 pregnant rats1 were randomly divided into different groups according to the study design, and 24 pregant females were dosed at 0, 100, 300 and 1000 mg/kg bw /day.
The following parameters and end points were evaluated in this study: Clinical signs, body weights, body weight gains, food consumption, gross pathology, gravid uterine weights, intrauterine growth and survival, number of corpora lutea, and fetus parameters [sex, weight and anogenital distance, and external, visceral and skeletal observations]. Approximately half of the fetuses from
each litter were examined for visceral malformations and the remaining half were evaluated for skeletal malformations. In addition, from each dam the thyroids were weighed and subjected to microscopic evaluation, and thyroid hormones were estimated from the blood collected at terminal sacrifie (GD20).
Results of the study are summarized below:
• Clinical signs and gross necropsy changes: There were no clinical signs, mortalities or gross pathological changes in treated rats at any of the doses tested.
• Maternal Parameters: No treatment-related effects on maternal body weights and food consumption up to the highest tested dose of 1000 mg/kg/day. The other maternal parameters comprising of uterine weight, number of corpora lutea, implantations and early and late resorptions, pre-and post implantation loss were comparable to vehicle control group up to the high dose of 1000 mg/kg/day. Gross evaluation of placenta revealed no findings.
• Litter Parameters: No treatment-related effects on litter parameters comprising of total number of fetuses, fetal weights, anogenital distance in male and female fetuses, were observed.
• Fetal examination: The fetal external, visceral and skeletal examinations revealed no signs of teratogenicity or developmental toxicity up to 1000 mg/kg/day.
• Thyroid hormone levels (T3, T4 and TSH), thyroid gland weights and histology of thyroid gland were unaffected by treatment with Diethylene Glycol Diformate up to the highest dose of 1000 mg/kg/day
Based on the above findings, it is concluded that, No Observed Adverse Effect Level (NOAEL) for
• Maternal toxicity is 1000 mg/kg/day as the maternal body weight and weight gain, corrected body weight gain and food consumption was unaffected up to 1000 mg/kg/day.
• Fetal developmental toxicity and Teratogencity is 1000 mg/kg/day as fetal resorptions or post implantation loss were comparable to the controls, no effects on fetal body weights and further the fetal external, visceral and skeletal examinations revealed no signs of teratogenicity or developmental toxicity up to 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.